ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

Abigail Alliance says statisticians usurped control of oncology. Milken’s optimism fuels the movement.

August 5, 2005

Mass. Congressman Pressed For $1.5 M Proton Beam Funds

August 18, 1989

In Brief: St. Jude To Stay In Memphis; Katterhagens Move To Illinois; ACCC, Nixon In DC Next Week

March 28, 1986

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

November 5, 2010